Your browser doesn't support javascript.
loading
Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth.
Cooke, Megan E; Knoll, Sarah J; Streck, Joanna M; Potter, Kevin; Lamberth, Erin; Rychik, Natali; Gilman, Jodi M; Evins, A Eden; Schuster, Randi M.
Affiliation
  • Cooke ME; Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.
  • Knoll SJ; Department of Psychiatry, Massachusetts General Hospital, USA.
  • Streck JM; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA.
  • Potter K; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA.
  • Lamberth E; Department of Psychiatry, Massachusetts General Hospital, USA.
  • Rychik N; Department of Psychiatry, Massachusetts General Hospital, USA.
  • Gilman JM; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA.
  • Evins AE; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA.
  • Schuster RM; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA. Electronic address: RSCHUSTER@mgh.harvard.edu.
Drug Alcohol Depend ; 256: 111096, 2024 Mar 01.
Article de En | MEDLINE | ID: mdl-38277735
ABSTRACT

BACKGROUND:

It is important to identify interventions that reduce harm in youth not motivated to change their cannabis use. This study evaluated how short-duration contingency management (CM) impacts cannabis use attitudes and behavior after abstinence incentives are discontinued among non-treatment seeking youth.

METHODS:

Participants (N=220) were randomized to 4 weeks of abstinence-based CM (CB-Abst; n=126) or monitoring (CB-Mon; n=94). Participants completed self-report and provided biochemical measures of cannabis exposure at baseline, end-of-intervention, and 4-week follow-up. Changes in self-reported cannabis use frequency (days/week; times/week) and biochemically verified creatinine-adjusted 11-nor-9-carboxy-tetrahydrocannabinol concentrations (CN-THCCOOH) were analyzed between groups from baseline to follow-up. In CB-Abst, cannabis use goals at end-of-intervention were described and changes in cannabis use at follow-up were explored by goals and cannabis use disorder (CUD) diagnosis.

RESULTS:

There was a group by visit interaction on cannabis use (days beta=0.93, p=0.005; times beta=0.71, p<0.001; CN-THCCOOH beta=0.26, p=0.004), with reductions at follow-up detected only in CB-Abst. Following 4 weeks of abstinence, 68.4% of CB-Abst participants wanted to reduce or abstain from cannabis use following completion of CM. Those in CB-Abst who set end-of-intervention reduction goals and were without CUD had greater decreases in cannabis use frequency at follow-up (Goals*time on days/week beta=-2.27, p<0.001; CUD*time on times/week beta=0.48, SE=0.24, t=2.01, p=0.048).

CONCLUSIONS:

Findings support the utility of brief incentivized abstinence for generating motivation to reduce cannabis use and behavior change even after incentives end. This study supports CM as a potentially viable harm reduction strategy for those not yet ready to quit.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cannabis / Abus de marijuana / Troubles liés à une substance / Hallucinogènes Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Humans Langue: En Journal: Drug Alcohol Depend Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cannabis / Abus de marijuana / Troubles liés à une substance / Hallucinogènes Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Humans Langue: En Journal: Drug Alcohol Depend Année: 2024 Type de document: Article
...